2023 Q2 Form 10-Q Financial Statement

#000111080323000035 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q2
Revenue $1.087B $1.083B $1.223B
YoY Change -11.12% -9.67% 11.89%
Cost Of Revenue $432.0M $411.0M $408.0M
YoY Change 5.88% 7.59% 24.01%
Gross Profit $655.0M $672.0M $815.0M
YoY Change -19.63% -17.75% 6.68%
Gross Profit Margin 60.26% 62.05% 66.64%
Selling, General & Admin $378.0M $432.0M $308.0M
YoY Change 22.73% 1.41% -17.65%
% of Gross Profit 57.71% 64.29% 37.79%
Research & Development $341.0M $346.0M $323.0M
YoY Change 5.57% -1.14% 63.96%
% of Gross Profit 52.06% 51.49% 39.63%
Depreciation & Amortization $57.00M $106.0M $50.00M
YoY Change 14.0% 19.1% 21.95%
% of Gross Profit 8.7% 15.77% 6.13%
Operating Expenses $719.0M $778.0M $631.0M
YoY Change 13.95% 0.26% 10.51%
Operating Profit -$64.00M -$106.0M $184.0M
YoY Change -134.78% -358.54% -4.66%
Interest Expense $20.00M -$31.00M $6.000M
YoY Change 233.33% -148.44% -68.42%
% of Operating Profit 3.26%
Other Income/Expense, Net -$14.00M -$10.00M -$44.00M
YoY Change -68.18% -47.37% 83.33%
Pretax Income -$78.00M -$168.0M $140.0M
YoY Change -155.71% -295.35% -17.16%
Income Tax -$81.00M -$29.00M $54.00M
% Of Pretax Income 38.57%
Net Earnings $3.000M -$139.0M $86.00M
YoY Change -96.51% -223.01% -41.5%
Net Earnings / Revenue 0.28% -12.83% 7.03%
Basic Earnings Per Share $0.02 $0.55
Diluted Earnings Per Share $0.02 -$0.89 $0.55
COMMON SHARES
Basic Shares Outstanding 158.0M shares 158.0M shares 157.0M shares
Diluted Shares Outstanding 158.0M shares 159.0M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.518B $2.037B $1.416B
YoY Change 7.2% 52.13% -69.42%
Cash & Equivalents $1.494B $2.011B $1.351B
Short-Term Investments $24.00M $26.00M $65.00M
Other Short-Term Assets $386.0M $268.0M $244.0M
YoY Change 58.2% -9.15% 86.26%
Inventory $586.0M $568.0M $465.0M
Prepaid Expenses
Receivables $665.0M $671.0M $614.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.172B $3.561B $2.755B
YoY Change 15.14% 31.26% -51.17%
LONG-TERM ASSETS
Property, Plant & Equipment $1.082B $1.091B $1.034B
YoY Change 4.64% 6.54% 13.01%
Goodwill $3.239B $3.239B $7.113B
YoY Change -54.46% -54.46% 692.98%
Intangibles $3.237B $3.285B $3.209B
YoY Change 0.87% 1.08% 2294.78%
Long-Term Investments $200.0M $211.0M $224.0M
YoY Change -10.71% 61.15%
Other Assets $423.0M $423.0M $457.0M
YoY Change -7.44% -4.94% -28.37%
Total Long-Term Assets $8.639B $8.691B $12.52B
YoY Change -30.99% -30.49% 302.15%
TOTAL ASSETS
Total Short-Term Assets $3.172B $3.561B $2.755B
Total Long-Term Assets $8.639B $8.691B $12.52B
Total Assets $11.81B $12.25B $15.27B
YoY Change -22.67% -19.48% 74.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $242.0M $293.0M $291.0M
YoY Change -16.84% -11.75% 63.48%
Accrued Expenses $1.239B $1.232B $700.0M
YoY Change 77.0% 61.89% 16.28%
Deferred Revenue $258.0M $245.0M $232.0M
YoY Change 11.21% 4.7% 23.4%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $749.0M $1.248B $499.0M
YoY Change 50.1% 2.25%
Total Short-Term Liabilities $2.230B $2.773B $1.490B
YoY Change 49.66% 153.71% 17.51%
LONG-TERM LIABILITIES
Long-Term Debt $1.487B $1.487B $1.241B
YoY Change 19.82% -12.27% -25.78%
Other Long-Term Liabilities $654.0M $649.0M $845.0M
YoY Change -22.6% -29.07% 269.0%
Total Long-Term Liabilities $654.0M $649.0M $845.0M
YoY Change -22.6% -29.07% 269.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.230B $2.773B $1.490B
Total Long-Term Liabilities $654.0M $649.0M $845.0M
Total Liabilities $2.884B $3.422B $2.335B
YoY Change 23.51% 70.42% 55.98%
SHAREHOLDERS EQUITY
Retained Earnings $1.145B $1.142B $5.632B
YoY Change -79.67% -79.18% 15.65%
Common Stock $2.000M $2.000M $2.000M
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.764B $3.755B $3.714B
YoY Change 1.35% 1.43% -4.08%
Treasury Stock Shares
Shareholders Equity $6.693B $6.599B $10.90B
YoY Change
Total Liabilities & Shareholders Equity $11.81B $12.25B $15.27B
YoY Change -22.67% -19.48% 74.46%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q2
OPERATING ACTIVITIES
Net Income $3.000M -$139.0M $86.00M
YoY Change -96.51% -223.01% -41.5%
Depreciation, Depletion And Amortization $57.00M $106.0M $50.00M
YoY Change 14.0% 19.1% 21.95%
Cash From Operating Activities $10.00M $147.0M $172.0M
YoY Change -94.19% -47.87% -39.01%
INVESTING ACTIVITIES
Capital Expenditures $52.00M $88.00M $61.00M
YoY Change -14.75% -225.71% 45.24%
Acquisitions
YoY Change
Other Investing Activities -$3.000M -$14.00M -$13.00M
YoY Change -76.92% -120.0% -100.92%
Cash From Investing Activities -$56.00M -$102.0M -$74.00M
YoY Change -24.32% -105.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $37.00M $33.00M
YoY Change 12.12% 6.45%
Debt Paid & Issued, Net $500.0M $0.00
YoY Change
Cash From Financing Activities -$473.0M 956.0M $21.00M
YoY Change -2352.38% -841.09% -97.83%
NET CHANGE
Cash From Operating Activities $10.00M 147.0M $172.0M
Cash From Investing Activities -$56.00M -102.0M -$74.00M
Cash From Financing Activities -$473.0M 956.0M $21.00M
Net Change In Cash -$517.0M 1.001B $119.0M
YoY Change -534.45% 554.25% -95.46%
FREE CASH FLOW
Cash From Operating Activities $10.00M $147.0M $172.0M
Capital Expenditures $52.00M $88.00M $61.00M
Free Cash Flow -$42.00M $59.00M $111.0M
YoY Change -137.84% -83.24% -53.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001110803
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-02
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
001-35406
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Illumina, Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0804655
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
5200 Illumina Way
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92122
CY2023Q2 dei City Area Code
CityAreaCode
858
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
202-4500
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2023Q2 dei Trading Symbol
TradingSymbol
ILMN
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
158100000 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1494000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2011000000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
24000000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
26000000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
665000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
671000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
586000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
568000000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
403000000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
285000000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
3172000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3561000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1082000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1091000000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
658000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
653000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
3239000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3239000000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3237000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3285000000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
423000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
423000000 usd
CY2023Q2 us-gaap Assets
Assets
11811000000 usd
CY2023Q1 us-gaap Assets
Assets
12252000000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
242000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
293000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1239000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1232000000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
500000000 usd
CY2023Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
749000000 usd
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
748000000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2230000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2773000000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
747000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
744000000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1487000000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
1487000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
654000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
649000000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
2000000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2000000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9311000000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9207000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1145000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1142000000 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3764000000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
3755000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6693000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6599000000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11811000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12252000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1087000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1223000000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
48000000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
40000000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
432000000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
408000000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
655000000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
815000000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
341000000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
323000000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
378000000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
308000000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
719000000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
631000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-64000000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
184000000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
17000000 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
20000000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
6000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-38000000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14000000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-44000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-78000000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
140000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
86000000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159000000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
86000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-4000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
1000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1000000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
87000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
10740000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
86000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
1000000 usd
CY2022Q2 ilmn Stock Issued During Period Net Of Repurchases Value
StockIssuedDuringPeriodNetOfRepurchasesValue
21000000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
79000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10895000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-535000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
12000000 usd
CY2022Q3 ilmn Stock Issued During Period Net Of Repurchases Value
StockIssuedDuringPeriodNetOfRepurchasesValue
-4000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
10444000000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3816000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
9000000 usd
CY2022Q4 ilmn Stock Issued During Period Net Of Repurchases Value
StockIssuedDuringPeriodNetOfRepurchasesValue
28000000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
66000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6731000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-139000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-36000000 usd
CY2023Q1 ilmn Stock Issued During Period Net Of Repurchases Value
StockIssuedDuringPeriodNetOfRepurchasesValue
-35000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
78000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
6599000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
6599000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-4000000 usd
CY2023Q2 ilmn Stock Issued During Period Net Of Repurchases Value
StockIssuedDuringPeriodNetOfRepurchasesValue
28000000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6693000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
86000000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
57000000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
50000000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41000000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
93000000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
92000000 usd
CY2023Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
17000000 usd
CY2022Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
21000000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-16000000 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-44000000 usd
CY2023Q2 ilmn Contingent Value Right Unrealized Gain Loss
ContingentValueRightUnrealizedGainLoss
3000000 usd
CY2022Q2 ilmn Contingent Value Right Unrealized Gain Loss
ContingentValueRightUnrealizedGainLoss
5000000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1000000 usd
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-49000000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7000000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1000000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31000000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18000000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34000000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17000000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11000000 usd
CY2023Q2 ilmn Increase Decrease Of Operating Leases Net
IncreaseDecreaseOfOperatingLeasesNet
5000000 usd
CY2022Q2 ilmn Increase Decrease Of Operating Leases Net
IncreaseDecreaseOfOperatingLeasesNet
3000000 usd
CY2023Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2000000 usd
CY2022Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-6000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-46000000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-39000000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-123000000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-45000000 usd
CY2023Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
11000000 usd
CY2022Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
8000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10000000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
172000000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52000000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61000000 usd
CY2023Q2 ilmn Payments For Strategic Investments
PaymentsForStrategicInvestments
3000000 usd
CY2022Q2 ilmn Payments For Strategic Investments
PaymentsForStrategicInvestments
13000000 usd
CY2023Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1000000 usd
CY2022Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56000000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74000000 usd
CY2023Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000000 usd
CY2022Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
500000000 usd
CY2022Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9000000 usd
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37000000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
33000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-473000000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21000000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-517000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
119000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2011000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1232000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1494000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1351000000 usd
CY2023Q2 us-gaap Fiscal Period
FiscalPeriod
Our fiscal year is the 52 or 53 weeks ending the Sunday closest to December 31, with quarters of 13 or 14 weeks ending the Sunday closest to March 31, June 30, September 30, and December 31. References to Q1 2023 and Q1 2022 refer to the three months ended April 2, 2023 and April 3, 2022, respectively, which were both 13 weeks.
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157000000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159000000 shares
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
245000000 usd
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1087000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1223000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1087000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1223000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1133000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.88
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.06
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
17000000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
17000000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
324000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
308000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
258000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
95000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
24000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
26000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2000000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-42000000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
28000000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
28000000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
8000000 shares
CY2023Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
220000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93000000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
92000000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
21000000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
21000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
72000000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
71000000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
855000000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
669000000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
675000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
665000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
671000000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
257000000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
247000000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
404000000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
386000000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27000000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28000000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
688000000 usd
CY2023Q1 us-gaap Inventory Gross
InventoryGross
661000000 usd
CY2023Q2 ilmn Effective Income Tax Rate Reconciliation Global Intangible Low Taxes Income And Us Foreign Tax Credits Amount
EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomeAndUSForeignTaxCreditsAmount
44000000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
102000000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
93000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
586000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
568000000 usd
CY2023Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
476000000 usd
CY2023Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
473000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
258000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
245000000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
187000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
188000000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
74000000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
97000000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
79000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
76000000 usd
CY2023Q2 ilmn Accrued Liability Classified Awards Current
AccruedLiabilityClassifiedAwardsCurrent
44000000 usd
CY2023Q1 ilmn Accrued Liability Classified Awards Current
AccruedLiabilityClassifiedAwardsCurrent
36000000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
121000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
117000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1239000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1232000000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
18000000 usd
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
22000000 usd
CY2023Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
9000000 usd
CY2022Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
6000000 usd
CY2023Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8000000 usd
CY2022Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
7000000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19000000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
21000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
2000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
5000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.039
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.383
CY2023Q2 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
49000000 usd
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
116000000 usd
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1087000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1223000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-64000000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
184000000 usd

Files In Submission

Name View Source Status
ilmn-20230402_lab.xml Edgar Link unprocessable
0001110803-23-000035-index-headers.html Edgar Link pending
0001110803-23-000035-index.html Edgar Link pending
0001110803-23-000035.txt Edgar Link pending
0001110803-23-000035-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fy23q1ex311.htm Edgar Link pending
fy23q1ex312.htm Edgar Link pending
fy23q1ex321.htm Edgar Link pending
fy23q1ex322.htm Edgar Link pending
ilmn-20230402.htm Edgar Link pending
ilmn-20230402.xsd Edgar Link pending
ilmn-20230402_g1.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ilmn-20230402_def.xml Edgar Link unprocessable
ilmn-20230402_cal.xml Edgar Link unprocessable
ilmn-20230402_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
ilmn-20230402_pre.xml Edgar Link unprocessable
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending